Detalles de la búsqueda
1.
Safety and efficacy of sunitinib in patients from Italy with metastatic renal cell carcinoma: final results from an expanded-access trial.
Oncology
; 88(5): 273-80, 2015.
Artículo
en Inglés
| MEDLINE | ID: mdl-25592399
2.
Maintenance single-agent bevacizumab or observation after first-line chemotherapy in patients with metastatic colorectal cancer: a multicenter retrospective study.
Invest New Drugs
; 31(4): 1035-43, 2013 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-23417697
3.
Peripheral lymphocyte subset counts predict antibody response after SARS-CoV-2 mRNA-BNT162b2 vaccine in cancer patients: Results from the Vax-On-Profile study.
Int Immunopharmacol
; 108: 108774, 2022 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-35461110
4.
Capecitabine and celecoxib as second-line treatment of advanced pancreatic and biliary tract cancers.
Oncology
; 76(4): 254-61, 2009.
Artículo
en Inglés
| MEDLINE | ID: mdl-19246950
5.
Quality of life, compliance, safety and effectiveness in fit older metastatic colorectal patients with cancer treated in first-line with chemotherapy plus cetuximab: A restrospective analysis from the ObservEr study.
J Geriatr Oncol
; 9(3): 243-248, 2018 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-29433905
6.
Observational study on quality of life, safety, and effectiveness of first-line cetuximab plus chemotherapy in KRAS wild-type metastatic colorectal cancer patients: the ObservEr Study.
Cancer Med
; 5(11): 3272-3281, 2016 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-27748041
7.
Epirubicin and docetaxel as first-line treatment for hormonal receptor positive metastatic breast cancer: the predictive value of luminal subtype: a retrospective cohort analysis.
J Chemother
; 25(2): 112-8, 2013 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-23684359
Resultados
1 -
7
de 7
1
Próxima >
>>